2021 American Transplant Congress
Safety and Tolerability of Tacrolimus Extended-Release (astagraf Xl) in Hla Sensitized Kidney Transplant Recipients: A Single Center Experience
Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: Pill burden is a limitation in kidney transplant. Tacrolimus extended-release (Astagraf XL) is a once daily formulation approved for kidney transplantation. Increased compliance could…2021 American Transplant Congress
Calcineurin Inhibitor Dose and Selection, Not Antiproliferatives or Steroids, Influence Development of DSA One Year Post-kidney Transplant
*Purpose: Allograft rejection is a serious complication in kidney transplantation (KT). Despite advances in immunosuppression, acute rejection remains a concern in the first year of…2021 American Transplant Congress
Factors Affecting Sensitization Following Kidney Allograft Failure
*Purpose: Kidney transplant (KT) recipients with failed allografts constitute nearly 12% of the current waitlist in the US. Sensitization as a result of graft failure…2021 American Transplant Congress
Identifying Health-System Level Barriers and Facilitators to Living Donor Kidney Transplantation: A Comparative Case Study
*Purpose: Despite the well-known advantages of living donor kidney transplantation (LDKT), rates at many centers have stagnated or declined. In Canada, there are large interprovincial…2021 American Transplant Congress
The Experience of 1000 Hand Assisted Laparoscopic Donor Nephrectomy for Living Donor Kidney Transplantation
*Purpose: Due to the profound organ shortage, living donor kidney transplantation becomes more necessary. Hand assisted laparoscopic donor nephrectomy (HALDN) is widely performed to lessen…2021 American Transplant Congress
Criteria and Practice Patterns for Accepting Living Donors with Prior Covid-19: A National Survey
*Purpose: A critical question facing transplant programs is if, when and how to safely accept living kidney donors (LKD) who have a history and recovered…2021 American Transplant Congress
Predictors of Prolonged Length of Stay in Pediatric Kidney Transplantation: Changes Over the Last Three Decades
Department of Abdominal Transplantation, Baylor College of Medicine, Houston, TX
*Purpose: Hospital length of stay (LOS) following kidney transplantation, particularly prolonged LOS, has not shown much improvement since the early 2000s. This study explores changes…2021 American Transplant Congress
Plasma Donor-Derived Cell-Free DNA Levels Risk-Stratify Kidney Allograft Injury with Isolated Transplant Glomerulitis
*Purpose: The Banff lesion Glomerulitis (g) characterizes the degree of microvascular glomerular inflammation. Some studies have demonstrated glomerulitis in the absence of C4d in association…2021 American Transplant Congress
Higher Calcineurin Inhibitor Levels Associate with Graft Outcomes in Kidney Recipients with De Novo Donor-specific Antibodies of Either Hla Class I or II
Nephrology, CHU de Québec- Université Laval, Québec, QC, Canada
*Purpose: The development of de novo anti-HLA donor specific antibodies (dnDSA) is associated with poorer outcomes in kidney transplant recipients. We and other previously reported…2021 American Transplant Congress
Cancer Among Kidney Transplant Recipients More Than 20 Years After Transplantation: PTLD Remains the Most Common Cancer Type Even in the Very Long-Term
Nephrology, University Hospital Zurich, Zurich, Switzerland
*Purpose: Due to an improved patient and kidney allograft survival, cancer is increasingly recognized as the major cause of death after kidney transplantation. Cancer risk…
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 139
- Next Page »